ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Avexa Limited
Industry Group: Biotechnology / Medical Research - Biotechnology

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Avexa Limited is an Australia-based biotechnology company with a focus on research and development of anti-infectives. The Company is developing drugs for the treatment of infectious diseases. During the fiscal year ended June 30, 2011 (fiscal 2011), the Company was engaged in anti-infective pharmaceutical programs and projects. The Company’s principal research programs focus on the discovery of medicines for the treatment of the diseases caused by human immunodeficiency virus (HIV) and vancomycin and methicillin-resistant bacteria. Apricitabine (ATC) is the Company’s nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection. HIV is the virus which causes acquired immunodeficiency syndrome (AIDS).

Financial Summary
BRIEF: For the fiscal year ended 30 June 2011, Avexa Limited's revenues decreased 2% to A$1.7M. Net loss decreased 89% to A$4.4M. Revenues reflect a decrease in sales income. Net loss reflects decrease in contract research and development expenses, lower raw materials & consumables expenses, decrease in personnel expenses excluding share-based payment expenses, lower occupancy costs and decreased depreciation expenses.

Business Address


576 Swan Street
Richmond, VIC 3121
Phone: 61-3-92084300
Fax: 61-3-92084004
http://www.avexa.com.au/

ASX Share Price Information
Current Price 0.029
Current Price Date 07/02/2012
52 Week Hi/Low 0.08 - 0.03
Avg Volume Last ten Days 0.67
ASX Company Sizing
Market Cap 24.58
Revenues 6.99
EBITDA -4.56
Net Income -4.40
Number of Employees 8
Enterprise Value 6.99
Research Analyst Forecast
Consensus Recommendation -
Target Price -
LT Growth Rate -
Projected P/E -
Sales -
EPS -
Profit -
DPS -
Share Ratios
EPS -0.00519
RPS 0.00195
BV per Share 0.03109
Cash per Share 0.02076
Cashflow per Share -0.00461
Cashflow per Share 0.00000
Financial Ratios
Gross Margin 85.71429
ROE -17.35668
Price/Sales 14.85376
P/E -
P/Book 0.93276